COL1A1 and COL1A2 sequencing results in cohort of patients undergoing evaluation for potential child abuse

Yuri A Zarate1, Rachel Clingenpeel2, Elizabeth A Sellars1

  • 1Section of Genetics and Metabolism, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

Insights

Routine genetic testing for Osteogenesis Imperfecta (OI) in suspected child abuse cases with no other clinical indicators has a low yield. Careful clinical evaluation is key to identifying children needing OI molecular testing.

Area of Science:

  • Pediatrics
  • Genetics
  • Forensic Medicine

Background:

  • Child abuse is a significant cause of pediatric fractures.
  • Osteogenesis Imperfecta (OI) is a common inherited condition leading to bone fragility and fractures.

Purpose of the Study:

  • To evaluate the diagnostic yield of molecular testing for Osteogenesis Imperfecta (OI) in children evaluated for abuse.
  • To determine the prevalence of OI in a cohort of children suspected of abuse.

Main Methods:

  • Retrospective analysis of clinical, laboratory, and radiographic data.
  • Molecular testing for COL1A1 and COL1A2 genes in 43 pediatric patients.
  • Case review to establish final diagnosis.

Main Results:

  • Pathogenic variants for mild OI were identified in 2 of 43 patients (5%), both with prior clinical suspicion.
  • No pathogenic variants were found in 35 patients where OI testing was ordered due to higher suspicion of maltreatment.
  • Child abuse was the final diagnosis in 34 cases (77%); no inherited metabolic bone disorders were identified.

Conclusions:

  • Routine OI genetic testing in child abuse evaluations without suggestive clinical findings has a low diagnostic yield.
  • Clinical assessment and medical history are crucial for identifying patients who may benefit from OI molecular testing.
  • This study underscores the importance of targeted genetic testing based on clinical presentation.

Related Concept Videos